DUBLIN--(BUSINESS WIRE)--The "Personalized Medicine Market Analysis by Product and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
The personalized medicine market size is estimated to be USD 625.4 million in 2021 and is expected to witness a CAGR of 8.62% during the forecast period 2022-2029. The rise in interest in biomarker discovery for therapy, diagnosis, and prognosis for customised medicine development, rising healthcare spending and presence of key market players are expected to drive the market. However, lack of proper regulation for personalized medicine is expected to restrain the market growth.
Segmentation: Personalized Medicine Market Report 2021-2029 Product (Revenue, USD Million)
- Personalized Medicine Therapeutics
- Personalized Medicine Diagnostics
- Personalized Nutrition & Wellness
- Personalized Medical Care
By Region (Revenue, USD Million)North America
- U.S
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Key Topics Covered:
1. Research Methodology
1.1.Study Objectives
1.2.Study Scope
1.3.Research Assumptions
1.4.Research Framework
1.4.1.Research Models
1.4.1.1.Bottom-up Approach
1.4.1.2.Top-down Approach
1.4.1.3.Data Triangulation
1.4.2.Data Procurement
1.4.2.1.Internal Database
1.4.2.2.Secondary Research
1.4.2.3.Purchased Database
1.4.2.4.Primary Research
1.4.3.Data Analysis
1.4.3.1.Data Validation
1.4.3.2.Market Size Estimation
1.4.3.3.Market Forecast Model
1.4.4.Quality Assessment
2. Introduction: Personalized Medicine
3. Executive Summary
3.1.Global Market Scenario
3.2.Segment Market Scenario
3.3.Geographic Market Scenario
3.4.COVID-19 Impact
3.5.Competitive Landscape
4. Market Dynamics
5. Market Environment Analysis
5.1.Porter's 5 Forces Analysis
5.2.PESTEL Analysis
5.3.Value Chain Analysis
5.4.SWOT Analysis
5.5.Benchmark
6. COVID-19 Impact Analysis: Personalized Medicine Market
6.1.COVID-19: Overview
6.2.COVID-19 Impact on the Global Market
6.3.COVID-19 Impact on the Regional Markets
7. Market Analysis by Product
7.1.Personalized Medicine Therapeutics
7.1.1.Personalized Medicine Therapeutics Market Forecast, 2021-2029 (USD Million)
7.2.Personalized Medicine Diagnostics
7.2.1.Personalized Medicine Diagnostics Market Forecast, 2021-2029 (USD Million)
7.3.Personalized Nutrition & Wellness
7.3.1.Personalized Nutrition & Wellness Market Forecast, 2021-2029 (USD Million)
7.4.Personalized Medical Care
7.4.1.Personalized Medical Care Market Forecast, 2021-2029 (USD Million)
8. Regional Market Analysis
8.1.Regional Market Trends
8.2.Regional Market: Comparative Analysis
9. North America Personalized Medicine Market
10. Europe Personalized Medicine Market
11. Asia Pacific Personalized Medicine Market
12. Latin America Personalized Medicine Market
13. MEA Personalized Medicine Market
14. Competitor Analysis
14.1.Market Share Analysis, 2021 & 2029
14.2.Competitive Mapping
14.3.Key Players Market Place Analysis
14.4.Major Recent Developments
15. Company Profiles
16. Conclusion & Recommendations
Companies Mentioned
- Syapse Inc. (US)
- 2bPrecise LLC (Israel)
- Foundation Medicine Inc. (US)
- Fabric Genomics (US)
- SOPHiA GENETICS SA (Switzerland)
- PierianDx Inc. (US)
- N-of-One Inc. (US)
- Human Longevity Inc. (US)
- Translational Software Inc. (US)
- Sunquest Information Systems Inc. (US)
- Gene42 Inc. (Canada)
- LifeOmic Health LLC (US)
- NantHealth Inc. (US)
- Tempus Labs Inc. (US)
- Flatiron Health Inc. (US)
- IBM Watson Group (US)
- Koninklijke Philips N.V. (Netherlands).
For more information about this report visit https://www.researchandmarkets.com/r/5mrpx5
